Mark Verratti is Chief Commercial Officer of MYRIAD GENETICS INC. Currently has a direct ownership of 289,277 shares of MYGN, which is worth approximately $4.69 Million. The most recent transaction as insider was on Sep 25, 2021, when has been sold 6,746 shares (Common Stock) at a price of $33.31 per share, resulting in proceeds of $224,709. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 289K
3.16% 3M change
15.83% 12M change
Total Value Held $4.69 Million

Mark Verratti Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 25 2021
SELL
Payment of exercise price or tax liability
$224,709 $33.31 p/Share
6,746 Reduced 3.17%
205,873 Common Stock
Sep 21 2021
BUY
Grant, award, or other acquisition
-
56,571 Added 21.02%
212,619 Common Stock
Aug 25 2021
SELL
Payment of exercise price or tax liability
$37,664 $34.81 p/Share
1,082 Reduced 0.69%
156,048 Common Stock
Mar 24 2021
BUY
Grant, award, or other acquisition
-
15,441 Added 8.95%
157,130 Common Stock
Oct 08 2020
BUY
Grant, award, or other acquisition
-
31,258 Added 18.07%
141,689 Common Stock
Sep 30 2020
SELL
Sale (or disposition) back to the issuer
$9,454 $13.04 p/Share
725 Reduced 0.65%
110,431 Common Stock
MV

Mark Verratti

Chief Commercial Officer
Salt Lake City, UT

Track Institutional and Insider Activities on MYGN

Follow MYRIAD GENETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN